112 related articles for article (PubMed ID: 20193522)
1. [The clinical features and risk factors for invasive fungal infection in multiple myeloma.].
Huang BH; Li J; Liu JR; Gu JL
Zhonghua Nei Ke Za Zhi; 2009 Dec; 48(12):1026-30. PubMed ID: 20193522
[TBL] [Abstract][Full Text] [Related]
2. [The clinical study of invasive fungal infection in 76 cases of hematologic diseases].
Wu FF; Sun H; Gan SL; Ma J; Liu YF; Xie XS; Sun L; Liu LX; Wan DM
Zhonghua Nei Ke Za Zhi; 2013 Mar; 52(3):218-20. PubMed ID: 23856113
[TBL] [Abstract][Full Text] [Related]
3. [An analysis of efficacy and related factors of itraconazole in the treatment of invasive fungal infection in hematological diseases].
Liu CY; Fu R; Wu YH; Ruan EB; Qu W; Wang GJ; Liang Y; Wang XM; Liu H; Song J; Guan J; Wang HQ; Xing LM; Li LJ; Wang J; Shao ZH
Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):504-7. PubMed ID: 20979739
[TBL] [Abstract][Full Text] [Related]
4. [Itraconazole for treatment of fungal infections in patients undergoing allogeneic hematopoietic stem cell transplantation].
Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):29-31. PubMed ID: 17331384
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of amphotericin B in the treatment of invasive fungal infection in 111 hematological disorder patients with neutrocytopenia].
Tong HY; Zhang FJ; Xiao F; Qian WB; Meng HT; Mai WY; Tong Y; Mao LP; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):472-5. PubMed ID: 19035181
[TBL] [Abstract][Full Text] [Related]
6. Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
Cherif H; Kalin M; Björkholm M
Eur J Haematol; 2006 Oct; 77(4):288-92. PubMed ID: 16856930
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients.
Liu F; Wu T; Wang JB; Cao XY; Yin YM; Zhao YL; Lu DP
Transpl Infect Dis; 2013 Jun; 15(3):243-50. PubMed ID: 23496156
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy and safety of itraconazole injection/oral solution sequential therapy for treatment of invasive fungal infection in intensive care unit].
; Qui HB
Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1012-6. PubMed ID: 19134307
[TBL] [Abstract][Full Text] [Related]
9. [The clinical efficacy and safety of itraconazole injection in treatment of invasive fungal infection in intensive care unit].
Collaborative Research Group of Itraconazole in Intensive Care Unit
Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):414-7. PubMed ID: 20646417
[TBL] [Abstract][Full Text] [Related]
10. [Invasive fungal infection in haematology patients].
Vallejo Llamas JC; Ruiz-Camps I
Enferm Infecc Microbiol Clin; 2012 Nov; 30(9):572-9. PubMed ID: 23079614
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective study of efficacy and safety of itraconazole for treatment of invasive fungal infection in hematologic diseases].
Ji Y; Huang XJ
Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1022-5. PubMed ID: 19134309
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic SCT in patients with a history of invasive fungal infection.
Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
[TBL] [Abstract][Full Text] [Related]
14. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
[TBL] [Abstract][Full Text] [Related]
15. [Current approaches to diagnosis and treatment of invasive fungal infection in HSCT recipients].
Shao Q; Shen DX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1619-23. PubMed ID: 20030960
[TBL] [Abstract][Full Text] [Related]
16. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
[TBL] [Abstract][Full Text] [Related]
17. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
Maertens J
Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
[TBL] [Abstract][Full Text] [Related]
18. [Itraconazole for secondary prophylaxis of invasive fungal infection in patients undergoing chemotherapy and stem cell transplantation].
Shi JM; Wang C; Zhou YH; Yu K; Du X; Luo Y; Cai Z; He JS; Ye XJ; Zhang J; Xie WZ; Huang H
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):413-6. PubMed ID: 23688752
[TBL] [Abstract][Full Text] [Related]
19. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of risk factors for invasive fungal infection after allogeneic stem cell transplantation in pediatric patients.
Kobayashi R; Kaneda M; Sato T; Suzuki D; Ichikawa M; Ariga T
J Pediatr Hematol Oncol; 2007 Nov; 29(11):786-91. PubMed ID: 17984700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
